30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PENICILLINS<br />

Gram positive<br />

aerobes<br />

Obligate<br />

anaerobes<br />

b-LACTAM ANTIBIOTICS<br />

PENICILLINS<br />

Gram negative<br />

aerobes<br />

Penicillinaseproducing<br />

Staphylococcus<br />

Excellent activity against most, although not necessarily all,<br />

pathogens in this quadrant<br />

Good activity against many pathogens in this quadrant but<br />

some important pathogens may be resistant<br />

Moderate activity against pathogens in this quadrant–<br />

unpredictable resistance patterns<br />

No useful activity against most pathogens in this quadrant,<br />

although there may be some individual exceptions–refer to<br />

individual drug information<br />

Fig. 8.1 Antimicrobial spectrum chart and key.<br />

Mechanism of action<br />

Penicillin G is derived from various Penicillium molds.<br />

Discovery of the penicillin nucleus, 6-aminopenicillanic<br />

acid, led to production of various semisynthetic penicillins.<br />

Those penicillins have been synthesized in an<br />

attempt to improve the spectrum, activity and stability<br />

of the parent compound. Many of the newer penicillins<br />

are modifications of ampicillin. For example, substitution<br />

of a carboxy group for the amino group of ampicillin<br />

on the acyl side chain produced carbenicillin and<br />

ticarcillin.<br />

Bacteria differ from animal cells by possessing a rigid<br />

outer layer, the cell wall. The bacterial cell possesses an<br />

unusually high internal osmotic pressure. Injury to the<br />

cell wall or inhibition of its synthesis may result in cell<br />

lysis. The peptidoglycan component of the cell wall is<br />

essential to the integrity of the bacterial envelope. It<br />

consists of alternating units of N-acetylglucosamine and<br />

N-acetylmuramic acid, crosslinked by short strands of<br />

peptides. Almost all bacteria have cell membranebinding<br />

proteins called penicillin-binding proteins<br />

(PBP). The PBPs are enzymes (transpeptidases, carboxypeptidases,<br />

endopeptidases) involved in the terminal<br />

stages of assembling the cell wall by crosslinking the<br />

peptidoglycan layer and reshaping the cell wall during<br />

growth and division. Binding of transpeptidase PBPs<br />

causes inhibition of peptidoglycan synthesis. The final<br />

step in the action of β-lactams probably involves inactivation<br />

of an inhibitor of autolytic enzymes in the<br />

cell wall.<br />

Penicillins are structural analogs of D-alanyl-Dalanine<br />

and bind with high affinity to those PBPs<br />

involved in cell wall synthesis. However, other PBPs act<br />

as β-lactamases and thus inactivate penicillins and cephalosporins.<br />

Bacteria have 3–6 PBPs and different PBPs<br />

possess different affinities for different drugs. The antibacterial<br />

activity of each β-lactam is dependent on its<br />

ability to bind one of the PBPs that form or maintain<br />

cell wall structure while avoiding destructive PBPs. PBPs<br />

are under chromosomal control and mutations can alter<br />

their number and affinity for different β-lactam drugs.<br />

The antibacterial spectrum of any penicillin depends<br />

primarily on its stability against bacterial β-lactamases<br />

but also its ability to reach the PBP on the cell membrane<br />

and its binding affinity for the target PBP.<br />

Differences in susceptibility of Gram-positive and<br />

Gram-negative bacteria to penicillins result from structural<br />

differences in cell walls, differences in receptor<br />

sites (PBPs) and binding affinity for the target PBP, the<br />

relative amount of peptidoglycan present (Grampositive<br />

bacteria possess far more) and to the different<br />

types of β-lactamase produced by bacteria. In Gramnegative<br />

bacteria the outer portion of the cell wall is a<br />

lipopolysaccharide and lipoprotein bilayer membrane,<br />

which may hinder the passage of drugs through the cell<br />

wall. All penicillins tend to be ionized at physiological<br />

pH so will not diffuse through the lipid bilayer of the<br />

Gram-negative outer membrane. The large hydrophobic<br />

groups on the narrow-spectrum penicillins (e.g. penicillin<br />

G) hinder their passage through the porins in most<br />

Gram-negative outer membranes. Substitution with<br />

more hydrophilic amino groups (e.g. ampicillin, amoxicillin)<br />

in place of the benzyl group allows the molecule<br />

to penetrate this barrier and so broadens the spectrum<br />

of activity. In contrast, Gram-positive organisms have a<br />

thin outer layer exterior to the peptidoglycan layer,<br />

which β-lactams can rapidly penetrate.<br />

Penicillins affect growing cells and have little influence<br />

on those that are dormant, so they should not be<br />

administered with bacteriostatic agents. The antibacterial<br />

action of penicillin is greatest during the periods of<br />

rapid bacterial multiplication. Penicillins (and cephalosporins)<br />

are time-dependent killers; thus the time for<br />

which plasma concentrations remain above MIC is the<br />

best predictor of treatment success and frequent dosing<br />

or depot formulations are therefore required.<br />

Mechanisms of resistance<br />

Resistance to β-lactams is mediated by induced β-<br />

lactamase production or by intrinsic means. β-<br />

lactamases are a diverse group of enzymes that hydrolyze<br />

the cyclic amide bond of the β-lactam ring and render it<br />

inactive. They were isolated from bacteria before β-<br />

159

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!